32 results on '"JAK-STAT pathway"'
Search Results
2. Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
3. Clinical features and prognosis of pediatric acute lymphocytic leukemia with JAK-STAT pathway genetic abnormalities: a case series
4. Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy
5. Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide
6. Phosphorylation of interferon regulatory factor 9 (IRF9)
7. The Dysregulation of Inflammatory Pathways Triggered by Copper Exposure
8. Drug Repurposing to Discover Novel Anti-Inflammatory Agents Inhibiting JAK3/STAT Signaling
9. Ex vivo effect of JAK inhibition on JAK-STAT1 pathway hyperactivation in patients with dominant-negative STAT3 mutations
10. Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations—10 Children and Review of the Literature
11. Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives
12. In-silico analysis unravels the structural and functional consequences of non-synonymous SNPs in the human IL-10 gene
13. Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow
14. Impaired JAK-STAT pathway signaling in leukocytes of the frail elderly
15. The sepsis induced defective aggravation of immune cells: a translational science underling chemico-biological interactions from altered bioenergetics and/or cellular metabolism to organ dysfunction
16. Association of PD-L1 and IDO1 expression with JAK–STAT pathway activation in soft-tissue leiomyosarcoma
17. Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride–induced liver fibrosis in mice
18. Interference with miR-210 Alleviated Renal Injury in Septic Rats by Inhibiting JAK-STAT Pathway
19. Development of JAK inhibitors for the treatment of immune-mediated diseases: kinase-targeted inhibitors and pseudokinase-targeted inhibitors
20. Short-term effectiveness of ruxolitinib in the treatment of recurrent or refractory hemophagocytic lymphohistiocytosis in children
21. Clinicopathological and molecular genomic features of monomorphic epitheliotropic intestinal T-cell lymphoma in the Chinese population: a study of 20 cases
22. Role of VHL-JAK-STAT signaling pathway in central nervous system hemangioblastoma associated with von Hippel-Lindau disease
23. JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren’s Syndrome
24. Screening of JAK-STAT modulators from the antiviral plants of Indian traditional system of medicine with the potential to inhibit 2019 novel coronavirus using network pharmacology
25. Current Approaches in the Management of Hepatic Adenomas
26. Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas
27. Inhibitory Effect and Mechanism of Mesenchymal Stem Cells Cultured in 3D System on Hepatoma Cells HepG2
28. Time-dependent antagonist-agonist switching in receptor tyrosine kinase-mediated signaling
29. Impairment of human neural crest cell migration by prolonged exposure to interferon-beta
30. Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
31. Primary Mediastinal Large B-cell Lymphoma
32. Innate immune responses in hepatitis C virus infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.